Telegram RegisterThe public register of Telegram
Telegram profile photo for Уротелиальная карцинома (канал)

Channel

Уротелиальная карцинома (канал)

@urothelialcancer

On this record: Topic · Growth · Engagement · Reactions · Posts · Polls · Citations · Cite this entry

242subscribers

+1 since we began measuring on 7 August 2026

Risers and fallers across the register · movement among entries of Under 1,000.

Register entry

Telegram ID-1001953832178
TypeChannel
Username@urothelialcancer
CreatedBetween 1 April 2023 and 31 October 2023 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded8 August 2026
Last confirmed live16 September 2026
Measurements held7
Confirmed unchanged2 times, most recently 16 September 2026
On Telegramt.me/urothelialcancer

Topic

Health & wellness — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 23 September 2026 and assigned it the closest of 31 fixed categories, at 97% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.

Growth

237244240.57 August 2026 — 241 subscribers8 August 2026 — 241 subscribers8 August 2026 — 242 subscribers16 August 2026 — 237 subscribers24 August 2026 — 244 subscribers30 August 2026 — 243 subscribers8 September 2026 — 242 subscribers2427 August 20268 September 2026
7 measurements spanning 32 days, net +1. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 236–245 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
8 Sept 2026, 06:37242-1
30 Aug 2026, 15:04243-1
24 Aug 2026, 01:58244+7
16 Aug 2026, 21:42237-5
8 Aug 2026, 15:43242+1
8 Aug 2026, 09:48241no change
7 Aug 2026, 17:44241first reading

Engagement

20 posts held, back to 20 July 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 7 August 2026. An engagement rate over an empty window would be a number about nothing.

Reaction mix

29 reactions across 10 posts, in 5 distinct kinds. The most used accounts for 31.0% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
❤931.0%
👍827.6%
🔥517.2%
🤔517.2%
👀26.90%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 10 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 29 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 20 most recent posts we hold, published 20 July 2026 to 7 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

7 Aug 2026, 11:26 UTC48 views1 reactionsread 8 August 2026
Forwarded from @oncology_news_2022Photo

Рак мочевого пузыря: эффективность платиносодержащей химиотерапии после EV+пембро В Eur J Cancer - результаты ретроспективного исследования (n=46) по оценке эффективности платиносодержащей ХТ у пациентов с распространенным уротелиальным раком с прогрессированием после терапии энфортумабом ведотином и пембролизумабом. По результатам - при медиане наблюдения 11,0 мес.: 🔹Частота объективного ответа 49%, медиана длител…

❤1

4 Aug 2026, 10:53 UTC97 views6 reactionsread 8 August 2026
File

💛 Надежда, которую несут новые методы лечения рака мочевого пузыря Делимся с вами переводом свежего и очень вдохновляющего выпуска подкаста Bladder Cancer Matters. 🔥 О чем этот выпуск? 💛 Смена парадигмы: Переход от исключительно хирургии и химиотерапии к комбинированному лечению. Иммунотерапия творит чудеса даже при метастатических формах. 💛Крестостимоген (Cretostimogene): Онколитический вирус, который избирательн…

❤3🔥2👍1

3 Aug 2026, 10:02 UTC126 views2 reactionsread 8 August 2026
File

💛 Систематический обзор стратегий обучения пациентов с онкологическими заболеваниями в странах с низким и средним уровнем дохода 💛Авторы изучали существующие подходы к обучению онкологических пациентов и оценке эффективности этого обучения в странах с низким и средним уровнем дохода. Главная цель: обобщить имеющиеся данные, выявить лучшие практики и определить пробелы в исследованиях, чтобы в будущем улучшить ранню…

❤2

2 Aug 2026, 07:42 UTC82 views2 reactionsread 8 August 2026
Photo

💛 Июль был насыщенным на важную и полезную информацию! Ниже подборка самых значимых публикаций месяца. 🎙️За пределами БЦЖ: что ждет пациентов с раком мочевого пузыря впереди? ✏️Гайдлайн NCCN по лечению рака мочевого пузыря 2.2026 🎞️ ЗАПИСЬ ЭФИРА (+ ПРЕЗЕНТАЦИЯ) С ФТИЗИАТРОМ: БЦЖ-терапия и риск туберкулеза 🕑 Наши ключевые ресурсы ⁉️Удаление мочевого пузыря: как выбрать тип отведения мочи? 💡Уротелиальная карцино…

🔥2

29 Jul 2026, 15:42 UTC120 viewsread 8 August 2026
Forwarded from @without_kidney_cancerPhoto

🌐 Коррупционные преступления в онкологии 💋 Петрова Татьяна Николаевна - https://onco.ru/archive/?id=dPK9WmSg1R0 Мы меняем систему здравоохранения не только словами, но и вниманием. Отметьте пост реакцией, если поддерживаете мысль о том, что пациент должен быть в диалоге с врачом, а не в подчинении. ➡️ Ссылки на все контакты сообщества: https://taplink.cc/kidneycancer #мир_без_рака_почки #without_kidney_cancer

25 Jul 2026, 07:44 UTC150 viewsread 8 August 2026
Poll

Какой препарат вызывает выраженную ототоксичность?

  1. Цисплатин70%
  2. Циклофосфамид5%
  3. Фторурацил15%
  4. Гемцитабин10%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

25 Jul 2026, 07:44 UTC163 views1 reactionsread 8 August 2026
Poll

Какой генетический тест важен перед назначением терапии ингибиторами FGFR?

  1. Анализ мутаций/слияний FGFR2/350%
  2. Определение статуса HER27%
  3. Анализ мутаций EGFR43%
  4. Тестирование на MSI0%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

🔥1

25 Jul 2026, 07:44 UTC128 viewsread 8 August 2026
Poll

Какой препарат является ингибитором FGFR, одобренным для уротелиальной карциномы с мутациями FGFR?

  1. Эрдафитиниб73%
  2. Иматиниб20%
  3. Сорафениб0%
  4. Лапатиниб7%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

25 Jul 2026, 07:44 UTC135 viewsread 8 August 2026
Poll

Какой препарат используется для лечения метастатического уротелиального рака после платины и иммунотерапии?

  1. Энфортумаб ведотин85%
  2. Цисплатин15%
  3. Метотрексат0%
  4. Винбластин0%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

25 Jul 2026, 07:44 UTC107 viewsread 8 August 2026
Poll

Какой ген ассоциирован с синдромом Линча?

  1. BRCA115%
  2. MLH154%
  3. TP5323%
  4. RB18%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

25 Jul 2026, 07:44 UTC109 viewsread 8 August 2026
Poll

Пембролизумаб - это...

  1. Химиотерапия11%
  2. Таргетная терапия11%
  3. Иммунотерапия74%
  4. Гормональная терапия5%

Shares as published, totalling 101%. No per-option vote count is published by Telegram, so none is shown.

25 Jul 2026, 07:44 UTC116 viewsread 8 August 2026
Poll

Что такое циркулирующая опухолевая ДНК (ctDNA)?

  1. ДНК здоровых клеток в крови0%
  2. Фрагменты ДНК опухолевых клеток в кровотоке93%
  3. Вирусная ДНК, интегрированная в геном7%
  4. Митохондриальная ДНК лейкоцитов0%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

Showing the 12 most recent of 20 posts we hold for @urothelialcancer. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Polls

The 6 most recent of 10 polls we hold for this entry, as Telegram rendered them when we read the post. A poll’s figures keep moving after that, so each one is dated.

25 Jul 2026, 07:44 UTCAnonymous Quiz13 voters

Какой ген ассоциирован с синдромом Линча?

  1. BRCA115%
  2. MLH154%
  3. TP5323%
  4. RB18%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

25 Jul 2026, 07:44 UTCAnonymous Quiz19 voters

Пембролизумаб - это...

  1. Химиотерапия11%
  2. Таргетная терапия11%
  3. Иммунотерапия74%
  4. Гормональная терапия5%

Shares as published, totalling 101%. No per-option vote count is published by Telegram, so none is shown.

25 Jul 2026, 07:44 UTCAnonymous Quiz14 voters

Что такое циркулирующая опухолевая ДНК (ctDNA)?

  1. ДНК здоровых клеток в крови0%
  2. Фрагменты ДНК опухолевых клеток в кровотоке93%
  3. Вирусная ДНК, интегрированная в геном7%
  4. Митохондриальная ДНК лейкоцитов0%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

25 Jul 2026, 07:44 UTCAnonymous Quiz16 voters

Что такое неоадъювантная терапия?

  1. Лечение после операции6%
  2. Лечение до хирургического вмешательства81%
  3. Поддерживающая терапия13%
  4. Экспериментальное лечение0%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

25 Jul 2026, 07:44 UTCAnonymous Quiz15 voters

Что такое опухолевая гетерогенность?

  1. Однородность опухолевых клеток7%
  2. Разнообразие клеточных популяций внутри опухоли67%
  3. Наличие только одного типа мутаций13%
  4. Универсальная чувствительность к лечению13%

Shares as published. No per-option vote count is published by Telegram, so none is shown.

25 Jul 2026, 07:44 UTCAnonymous Quiz19 voters

Какой препарат является стандартом первой линии системной терапии при метастатической уротелиальной карциноме?

  1. Доксорубицин + циклофосфамид0%
  2. Метотрексат + винбластин0%
  3. 5-фторурацил + лейковорин0%

Shares as published, totalling 0%. No per-option vote count is published by Telegram, so none is shown.

Percentages only — there are no per-option vote counts here, because Telegram publishes none. The public post preview gives each option’s share and a single voter total, and nothing else. Multiplying one by the other would produce a per-option tally that looks measured and is not: the shares are rounded to whole numbers before we ever see them. We print what was published and leave the column that does not exist empty.

The shares need not add up to 100. Rounding alone puts many polls at 99 or 101. A poll that allows more than one answer per voter runs well past 100 by design, and several here do. The bars are drawn against a fixed 100% track at each option’s own percentage rather than normalised to the total, so a poll that exceeds it shows that it does instead of being quietly rescaled.

Read from the 20 most recent posts we hold, published 20 July 2026 to 7 August 2026. Telegram labels each poll by kind — an anonymous poll, a quiz, a closed set of final results — and that label is reproduced rather than paraphrased.

Forward network

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 8 September 2026 — this entry's latest reading, not the date you are reading this.

“Уротелиальная карцинома (канал)” (@urothelialcancer), 242 subscribers as measured 8 September 2026. Telegram Register, tgregister.com/channel/urothelialcancer.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.